<em>Compliance Week</em> interviews Howard W. Goldstein on increased FCPA enforcement within the pharmaceutical industry

Compliance Week interviews Howard W. Goldstein on increased FCPA enforcement within the pharmaceutical industry

New York litigation partner Howard W. Goldstein was quoted in an article about the Department of Justice's (DOJ) increased enforcement of the Foreign Corrupt Practices Act (FCPA) within the pharmaceutical industry. Commenting on when to disclose a FCPA issue, Mr. Goldstein's stated, "A centralized compliance function is the best way to achieve that. People who focus on compliance exclusively tend to develop a 'sixth sense' about whether a situation requires further investigation."

news-detail.inc